Amyloid β-peptides inhibit Na+/K+-ATPase: Tissue slices versus primary cultures

Brain Research Bulletin

Volumn 46, Issue 5, 1998, Pages 423-427

  Bores, G M ^a   Smith, C P ^a   Wirtz Brugger, F ^a   Giovanni, A ^a  

^a SANOFI   (France)

Author keywords

A 1 40; A 1 42; A 25 35; Alzheimer's disease; Lactate dehydrogenase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; FETUS; HIPPOCAMPUS; NERVE CELL NECROSIS; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; CELL DEATH; CELLS, CULTURED; CEREBRAL CORTEX; CULTURE TECHNIQUES; ENZYME INHIBITORS; HIPPOCAMPUS; KINETICS; L-LACTATE DEHYDROGENASE; NA(+)-K(+)-EXCHANGING ATPASE; NEUROTRANSMITTER AGENTS; OUABAIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032527386     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(97)00382-1     Document Type: Article

References (15)

1. Decker, T.; Lohmann-Matthes, M. L. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods 15:61; 1988.
2. Hoshi, M.; Takashima, A.; Noguchi, K.; Murayama, M.; Sato, M.; Kondo, S.; Saitoh, Y.; Ishiguro, K.; Hoshino, T.; Imahori, K. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase 3/3 in brain. Proc. Nat. Acad. Sci. 93:2719-2723; 1996.
3. Hoshi, M.; Takashima, A.; Noguchi, K.; Murayama, M.; Yasutaka, K.; Yoshida, N.; Ishiguro, K.; Hoshino, T.; Imahori, K. Nontoxic amyloid β peptide 1-42 suppresses acetylcholine synthesis. J. Biol. Chem. 272:2038-2041; 1997.
4. Kar, S.; Seto, D.; Gaudreau, P.; Quirion, R. β-Amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices. J. Neurosci. 16:1034-1040; 1996.
5. Lees, G.J. Inhibition of sodium-phosphate-ATPase: A potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brain Res. Rev. 16:283-300; 1991.
6. i) in rat cortex: Effects of sodium channel blockers. Soc. Neurosci. 22:2111; 1996.
7. 3H]norepinephrine (NE) and enhances the internal calcium response to low potassium in rat cortex: Prevention with a free radical scavenger. Brain Res. Bull. 39:299-303; 1996.
8. 2+-ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease. Neurosci. Lett. 112:238-342; 1990.
9. +-ATPase activity in hippocampal neurons. Brain Res. 756:205-214; 1997.
10. 2+ homeostasis and cell death. J. Neurosci. 15: 6239-6249; 1995.
11. Mark, R. J.; Mattson, M. P. Amyloid β-protein (25-35) disrupts plasma membrane ATPase activity in cultured rat embryonic corical neurons. Neuro. Biol. Aging 15:586; 1994.
12. +-ATPase in renal tubule cells. Proc. Nat. Acad. Sci. USA. 20:8068-8072; 1989.
13. 3H]dopamine in rat striatal slices. Neurochem. Int. 28:501-507; 1996.
14. Milusheva, E.; Doda, M.; Paztor, E.; Lajtha, A.; Sershen, H.; Vizi, E. S. Regulatory interactions among axon terminals affecting the release of different transmitters from rat striatal slices under hypoxic and hypoglycemic conditions. J. Neurochem. 59:946-952; 1992.
15. Rohn, T. T.; Hinds, T. R.; Vincenzi, F. F. Ion transport ATPases as targets for free radical damage. Chem. Pharmacol. 46:525-534; 1993.